Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1998 1
2003 3
2005 4
2006 3
2007 3
2008 3
2009 3
2010 1
2011 5
2012 6
2013 5
2015 2
2016 2
2017 2
2018 4
2019 5
2020 2
2021 4
2022 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

51 results

Results by year

Filters applied: . Clear all
Page 1
Elotuzumab Therapy for Relapsed or Refractory Multiple Myeloma.
Lonial S, Dimopoulos M, Palumbo A, White D, Grosicki S, Spicka I, Walter-Croneck A, Moreau P, Mateos MV, Magen H, Belch A, Reece D, Beksac M, Spencer A, Oakervee H, Orlowski RZ, Taniwaki M, Röllig C, Einsele H, Wu KL, Singhal A, San-Miguel J, Matsumoto M, Katz J, Bleickardt E, Poulart V, Anderson KC, Richardson P; ELOQUENT-2 Investigators. Lonial S, et al. Among authors: oakervee h. N Engl J Med. 2015 Aug 13;373(7):621-31. doi: 10.1056/NEJMoa1505654. Epub 2015 Jun 2. N Engl J Med. 2015. PMID: 26035255 Free article. Clinical Trial.
Advanced Imaging Modalities to Monitor for Cardiotoxicity.
Seraphim A, Westwood M, Bhuva AN, Crake T, Moon JC, Menezes LJ, Lloyd G, Ghosh AK, Slater S, Oakervee H, Manisty CH. Seraphim A, et al. Among authors: oakervee h. Curr Treat Options Oncol. 2019 Aug 8;20(9):73. doi: 10.1007/s11864-019-0672-z. Curr Treat Options Oncol. 2019. PMID: 31396720 Free PMC article. Review.
Optimising cardiovascular care of patients with multiple myeloma.
Fontes Oliveira M, Naaktgeboren WR, Hua A, Ghosh AK, Oakervee H, Hallam S, Manisty C. Fontes Oliveira M, et al. Among authors: oakervee h. Heart. 2021 Nov;107(22):1774-1782. doi: 10.1136/heartjnl-2020-318748. Epub 2021 Apr 5. Heart. 2021. PMID: 33820757 Review.
Cessation of Ciprofloxacin Prophylaxis in Hemato-Oncology Patients.
Caldwell L, Bapat A, Drumright LN, Lambourne J, Jimenez-England FG, Aries J, Eccersley L, Hallam S, Montoto S, Oakervee H, Riches J, Agrawal SG. Caldwell L, et al. Among authors: oakervee h. Clin Infect Dis. 2022 Aug 24;75(1):178-179. doi: 10.1093/cid/ciab1000. Clin Infect Dis. 2022. PMID: 34864924 Free PMC article. No abstract available.
Bortezomib for multiple myeloma.
Popat R, Joel S, Oakervee H, Cavenagh J. Popat R, et al. Among authors: oakervee h. Expert Opin Pharmacother. 2006 Jul;7(10):1337-46. doi: 10.1517/14656566.7.10.1337. Expert Opin Pharmacother. 2006. PMID: 16805719 Review.
Clinical outcome of coronavirus disease 2019 in haemato-oncology patients.
Aries JA, Davies JK, Auer RL, Hallam SL, Montoto S, Smith M, Sevillano B, Foggo V, Wrench B, Zegocki K, Agrawal S, Le Dieu R, Truelove E, Erblich T, Araf S, Okosun J, Oakervee H, Cavenagh JD, Gribben JG, Riches JC. Aries JA, et al. Among authors: oakervee h. Br J Haematol. 2020 Jul;190(2):e64-e67. doi: 10.1111/bjh.16852. Epub 2020 Jun 10. Br J Haematol. 2020. PMID: 32420609 Free PMC article. No abstract available.
Adipocytes disrupt the translational programme of acute lymphoblastic leukaemia to favour tumour survival and persistence.
Heydt Q, Xintaropoulou C, Clear A, Austin M, Pislariu I, Miraki-Moud F, Cutillas P, Korfi K, Calaminici M, Cawthorn W, Suchacki K, Nagano A, Gribben JG, Smith M, Cavenagh JD, Oakervee H, Castleton A, Taussig D, Peck B, Wilczynska A, McNaughton L, Bonnet D, Mardakheh F, Patel B. Heydt Q, et al. Among authors: oakervee h. Nat Commun. 2021 Sep 17;12(1):5507. doi: 10.1038/s41467-021-25540-4. Nat Commun. 2021. PMID: 34535653 Free PMC article.
Clinical proof of concept for a safe and effective NF-κB-targeting strategy in multiple myeloma.
Tornatore L, Capece D, D'Andrea D, Begalli F, Verzella D, Bennett J, Acton G, Campbell EA, Kelly J, Tarbit M, Adams N, Bannoo S, Leonardi A, Sandomenico A, Raimondo D, Ruvo M, Chambery A, Oblak M, Al-Obaidi MJ, Kaczmarski RS, Gabriel I, Oakervee HE, Kaiser MF, Wechalekar A, Benjamin R, Apperley JF, Auner HW, Franzoso G. Tornatore L, et al. Among authors: oakervee he. Br J Haematol. 2019 May;185(3):588-592. doi: 10.1111/bjh.15569. Epub 2018 Sep 26. Br J Haematol. 2019. PMID: 30255568 Free article. No abstract available.
How to Simplify the Evaluation of Newly Introduced Chemotherapeutic Interventions in Myeloma.
Morris TCM, Drake MB, Kettle PJ, McGuigan T, Leahy M, O'Dwyer M, Enright H, O'Shea T, Popat R, Oakervee HE, Yong K, Cavenagh JD, Cairns DA, Alvarez-Iglesias A, Cook G. Morris TCM, et al. Among authors: oakervee he. Clin Hematol Int. 2021 Feb 8;3(1):27-33. doi: 10.2991/chi.k.210201.001. eCollection 2021 Mar. Clin Hematol Int. 2021. PMID: 34595464 Free PMC article.
51 results